Mayne Pharma in trading halt pending news on takeover bid by Cosette
Make us a preferred source
Make us a preferred source on Google
The news: Mayne Pharma Group is in a trading halt ahead of an announcement related to its proposed acquisition by Cosette Pharmaceuticals.
The context: It is expected that its shares will remain in the trading halt until 21 May.
In February, US-based Cosette agreed to acquire Mayne Pharma at a price of $7.40 per share, valuing the pharmaceutical company at $672 million. Mayne Pharma’s shares last closed at $6.48.
The source: ASX
